Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

AT&T Stock: Bull vs. Bear


Long-term shareholders in AT (NYSE: T) don't have much to be happy about. Against the backdrop of the S 500 index's 166% rally over the last decade, the telecom company's share price has fallen by roughly 44%. The stock is also down 20.5% this year alone.

Is AT a smart buy now considering its big dividend yield and meager price-to-earnings ratio, or is it a value trap destined to serve up even more disappointment for shareholders? Two Motley Fool contributors have vastly different takes on where this telecom stock is headed. 

Keith NoonanNo doubt about it, AT has its share of problems. The company still has a huge amount of debt on its books, its history of acquisitions is littered with duds, and its sales and earnings growth will likely proceed AT slow paces even in optimistic scenarios due to the competitive environments of the categories it operates in. 

Continue reading


Source Fool.com

Allergy Therapeutics PLC Stock

?
0.000%
The Allergy Therapeutics PLC price is unchanged compared to yesterday.

Like: 0
T
Share

Comments